Vanucizumab

DB12317InvestigationalProtein Based Therapies

Vanucizumab has been used in trials studying the treatment of ColoRectal Cancer and Advanced/Metastatic Solid Tumors.

Mechanism: Pharmacologically active on Angiopoietin-2 and Vascular endothelial growth factor A, long form
Curator reviewed

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

381Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with Vanucizumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.